EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+13.43%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$219M
AUM Growth
+$219M
Cap. Flow
-$13.4M
Cap. Flow %
-6.11%
Top 10 Hldgs %
75.45%
Holding
43
New
7
Increased
6
Reduced
10
Closed
9

Top Buys

1
GLPG icon
Galapagos
GLPG
$10.7M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
$9.51M
3
DERM
Dermira, Inc.
DERM
$7.96M
4
NTLA icon
Intellia Therapeutics
NTLA
$6.63M
5
AKAO
Achaogen, Inc.
AKAO
$5.96M

Top Sells

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
$20.3M
2
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$10.5M
3
EPZM
Epizyme, Inc
EPZM
$8.64M
4
AIMT
Aimmune Therapeutics, Inc.
AIMT
$7.07M
5
KITE
Kite Pharma, Inc.
KITE
$6.89M

Sector Composition

1 Healthcare 90.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EIGR
26
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$281K 0.11%
14,190
-175,355
-93% -$3.47M
AIMT
27
DELISTED
Aimmune Therapeutics, Inc.
AIMT
– –
-521,366
Closed -$7.07M
FPRX
28
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-500,757
Closed -$20.3M
GBT
29
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-28,032
Closed -$445K
IMGN
30
DELISTED
Immunogen Inc
IMGN
– –
0
– –
ATYR
31
aTyr Pharma
ATYR
$560M
– –
-74,959
Closed -$295K
XNTK icon
32
SPDR NYSE Technology ETF
XNTK
$1.24B
– –
0
– –
SLRX icon
33
Salarius Pharmaceuticals
SLRX
$2.45M
– –
-575,925
Closed -$6.32M
LRMR icon
34
Larimar Therapeutics
LRMR
$337M
– –
0
– –
GILD icon
35
Gilead Sciences
GILD
$140B
– –
0
– –
CPXX
36
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
– –
-950,000
Closed -$10.5M
KITE
37
DELISTED
Kite Pharma, Inc.
KITE
– –
-150,000
Closed -$6.89M
LOXO
38
DELISTED
Loxo Oncology, Inc
LOXO
– –
-150,308
Closed -$4.11M
ARRY
39
DELISTED
Array Biopharma Inc
ARRY
– –
0
– –
ONCE
40
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-8,700
Closed -$257K
AGN
41
DELISTED
Allergan plc
AGN
– –
0
– –
1
2